Whitepaper: Estimating the Impact of COVID-19 on Healthcare Costs in 2020– Key Factors of the Cost Trajectory1 min read

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email

Conventional wisdom holds that COVID-19 is increasing costs for healthcare payers due to an influx of patients in need of testing and treatment. While these costs are significant, a Milliman analysis reveals that the deferred and elimination of care is a far more impactful driver of costs. Milliman projects a net reduction in medical costs for healthcare payers by at least $75 billion and as much as $575 billion if the deferral and elimination of care continues through the end of 2020. Download the Milliman whitepaper. 

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email

Leave a Reply

Your email address will not be published.